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Case Presentation 
A 45-year-old white, college-educated,
right-handed woman was referred to the
Boston University Neurology Associates
Neuropsychology Service by her neurolo-
gist. She was reportedly exposed to carbon
monoxide while at work in a restaurant and
suffered from subsequent changes in behav-
ior and cognition. She was referred for an
evaluation to rule out CO-associated central
nervous system (CNS) dysfunction. She was
initially seen on 15 April 1998.
According to the patient, she discovered
that she had been exposed to CO in
November 1996, when she came to work
early, noticed the smell of gas, and called the
gas company. She said that the gas company
employee informed her that there were
extremely high levels of CO in the kitchen
where she worked as a restaurant cook. The
patient went to the hospital approximately 6
hr after leaving her workplace on the day she
called for help, but, at that time, her carboxy-
hemoglobin was reportedly not elevated and
no focal neurologic signs were noted. She
explained that she had been off work for 5
days and, immediately upon arriving at work
the morning the leak was detected, she sought
fresh air and did not have further exposure.
The restaurant was then closed for 2 weeks so
the furnace, which was the source of the CO
fumes, could be replaced. The patient
believed that CO had been leaking into her
workplace for at least a year, given the dura-
tion of her symptoms. 
We were unable to obtain a copy of the
gas company reports on levels taken on the
day that the leak was identiﬁed (the company
refused to release them to us). Because no
records were available on the levels of CO
before the gas leak was identified, it was
impossible to model the apparent chronic,
long-term exposure to CO experienced by the
patient. However, correspondence in the
medical record and communication with the
insurance company for the building in which
the exposure occurred documented the exis-
tence of exposure. 
The patient was not certain when her
symptoms began, but she said that they
peaked in January–April 1996. She reported
feeling as though she had a severe case of ﬂu
(influenza). Her symptoms included being
unable to walk straight, bumping into things,
balance problems resulting in several falls,
severe headaches that persisted 24 hr/day,
exhaustion, ear problems (especially on the
right), a “cloudy” sensation, an inability to
talk clearly or to produce a full sentence, tin-
gling or numbness in both thighs, difficulty
hearing, irritability, brittle teeth, and pain in
her face. The patient reported taking echi-
nacea and golden seal to treat her symptoms,
but in May 1996 she decided to consult a
physician, who diagnosed a sinus infection
and prescribed amoxicillin. She indicated
that she stopped the herbs at that time, but
when her symptoms became so severe that
she could not finish the amoxicillin, she
resumed taking the echinacea. The patient
stated that the echinacea allowed her to “get
through the day.”
The patient said that after the identiﬁca-
tion of the CO exposure, most of her symp-
toms resolved. The only symptoms that
continued to cause distress at the time of neu-
ropsychological testing (17 months later)
were difficulties in reading, writing, and
speaking. She stated, for example, that she
sometimes omitted a letter while writing a
word. She also said that she sometimes had
trouble ﬁnding a word that she wanted to say,
and she sometimes mispronounced words. 
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Articles
A 45-year-old woman experienced long-term, chronic exposure to carbon monoxide in the restau-
rant kitchen where she was employed as a cook. After returning to the restaurant after 5 days off
work, she noticed that her symptoms returned immediately; she then aired out the room and
called the gas company. Approximately 6 hr after a leak was detected, the patient went to the hos-
pital, where her carboxyhemoglobin was found to be within normal limits and results of a neuro-
logic examination were described as normal. Based on her symptoms, the patient believed she had
been exposed to CO for at least 1 year before the leak was discovered. Initially, she experienced
ﬂu-like symptoms, which eventually resolved. At the time of her ﬁrst neuropsychological evalua-
tion (17 months after the exposure was identiﬁed), her persisting complaints included difﬁculties
in reading, writing, speaking and word retrieval. The test results were consistent with secondary
frontal lobe dysfunction associated with subcortical disorders such as those seen after CO expo-
sure. Results of a subsequent neuropsychological examination (29 months postexposure) showed
slight improvement in performance, but her performance was still consistent with mild
frontal/subcortical dysfunction. Although the initial screening of a brain magnetic resonance
image (MRI) performed 15 months after the exposure was interpreted as being within normal
limits, two subsequent blind reviews of the same scans identiﬁed multiple bilateral lesions in the
basal ganglia, which were consistent with chronic CO exposure. We present this case as an exam-
ple of the utility of MRI and neuropsychological examinations in detecting central nervous system
dysfunction secondary to CO exposure. Key words: carbon monoxide, neuropsychology, toxicant-
induced encephalopathy, neuroimaging, MRI, neurobehavioral methods. Environ Health Perspect
110:1051–1055 (2002). [Online 6 September 2002]
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of Public Health and Arts and Sciences, Boston University, Boston, Massachusetts, USAThe patient reported that her neurologist
had ordered a magnetic resonance image
(MRI) of the brain, which was read as nor-
mal, and that he then informed her that he
could ﬁnd no evidence that she had suffered a
CO-induced encephalopathy; her neurologic
examination was described as being normal.
Relevant History
The patient denied any history of birth
trauma, hypertension, closed head injury, loss
of consciousness, seizures, diabetes, or thyroid
problems. She also denied ever having had
asthma; although she reported being allergic
to ragweed and grasses in her teens, she indi-
cated that this allergy disappeared when she
was in her 20s. She reported having had two
allergic episodes after being exposed to chem-
ical fumes; both episodes occurred after expo-
sure to paint stain. She denied sensitivity to
perfume, gasoline, or foods.
The patient provided the following infor-
mation on her education and skills: she had
received a full scholarship to college and had
earned a bachelor’s degree in fine arts; her
best subjects in school were languages, read-
ing, and writing, and her most difﬁcult sub-
ject was higher math; her employment history
included teaching and cooking. The patient
reported that she had worked for 2 years at
the restaurant where she was reportedly
exposed to CO.
At the time of the evaluation, the patient
stated that her mood was “good.” The only
medication she reported taking was ibupro-
fen, as needed, for knee pain, and she denied
any signiﬁcant history of drug or alcohol use.
Summary of neuropsychological func-
tioning. Time 1. The patient’s performance
on neuropsychological tests on 15 April 1998
(Time 1; 17 months after exposure) was
within the superior-to-very-superior range
across most cognitive tasks. However, her
performance was below expectations for esti-
mated premorbid abilities on demanding
tasks that assessed attention, learning, mem-
ory retrieval, and mood. Occasional atten-
tional lapses, perseveration, sequencing
problems, and slight concreteness were seen
throughout testing. Some word retrieval
problems were noted on confrontational
naming, but her performance was generally
aided by cues. Initial learning and retrieval of
new information on tests of short-term mem-
ory was below expectation, given the patient’s
intellectual potential, and she displayed sensi-
tivity to interference when completing mem-
ory tasks. Her responses to a mood inventory
raised the possibility of some unacknowl-
edged depressive symptomatology (Table 1).
Test results were suggestive of subtle
frontal lobe dysfunction and were of the type
seen in secondary frontal lobe deficit associ-
ated with subcortical disorders such as those
involving the basal ganglia. The deficits
observed were typical of those we have seen
residually in patients with histories of chronic
low level CO exposure not producing loss of
consciousness.
Time 2. Neuropsychological testing was
repeated on 28 April 1999 (Time 2; 29
months after exposure). Some variability was
seen on Time 2 testing relative to Time 1,
with increases in some scores and decreases in
others. The patient continued to score below
expectations for her premorbid very superior
intellectual potential on challenging memory
tasks that involved interference and on com-
plex verbal reasoning tasks with executive sys-
tem components. In addition, executive
system signs, such as perseveration, pull to
stimulus, and poor development of strategies,
continued to be evident. Her performance
diminished significantly on a test of psy-
chomotor speed. Test results again revealed
mild frontal/subcortical dysfunction. If any-
thing, the pattern of frontal/subcortical difﬁ-
culties was slightly improved from prior
testing (Table 1).
Neuroimaging. An MRI of the brain per-
formed on a GE Signa 1.5 Tesla scanner
(General Electric Medical Systems, Milwaukee,
WI) 26 February 1998 (15 months after
detection of CO exposure) was read as nor-
mal by the radiology department where it
was performed. We requested the original
films for additional analyses because the
neuropsychological findings were abnormal.
The scan was independently read blind to
history by two MRI experts at the VA Boston
Healthcare System (Jamaica Plain campus), a
board-certiﬁed neuroradiologist and a neuro-
scientist who does neuroimaging research.
They concurred that the Fast Spin Echo MRI
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Table 1. Neuropsychological test results.
Domain and neuropsychological test Time 1 Time 2
General intelligence (premorbid estimate = very superior)
WAIS-III
Verbal IQ 135 130
Performance IQ 121 128
Full Scale IQ 132 133
Mini Mental Status Examination 29 30
Attention, executive function
Attention Index, WMS-R 127 118
Digit Span
WAIS-III
Age-scaled score 17 17
Forward span (backward span) 8 (8) 9 (8)
Wisconsin Card Sorting Test
Completed sets/number of trials 6/70 6/73
WAIS-III 
Arithmetic (age-scaled score) 14 15
Comprehension (age-scaled score) 16 13
Similarities (age-scaled score) 12* 12*
Letter-number sequencing (age-scaled score) 13 NA
Trail making test 
Trails A time (errors) 22 sec (0) 15 sec (0)
Trails A (percentile) 90th > 90th
Trails B time (errors) 75 sec (1)* 48 sec (0)
Trails B (percentile) 50th–75tha,* 75th–90th
Continuous performance test
A errors 0 0
XI errors 0 0
Trails errors 1 0
Verbal, language
WAIS-III
Information (age-scaled score) 14 14
Vocabulary (age-scaled score) 18 16
Controlled Oral Word Association Test
Number of words 56 40
Percentile > 95% 60–64%
Categories (total, percentile) NA 34, 10th–25th*
Motor (handedness: right)
Finger tapping
Right 59.8 58.0
Left 54.8 54.0
Grooved pegboard
Right 55 67
Left 61 74
WAIS-III
Digit symbol (age-scaled score) 15 11*
Continued, next page[TR (time to radio frequency) = 6000; TE
(time to echo) = 105/Ef] revealed multiple
small lesions bilaterally in the basal ganglia
(more severe in the globus pallidus than the
putamen), which the radiologist reported to
be consistent with chronic CO exposure
(Figure 1).
Discussion
Carbon monoxide is a highly toxic, odorless,
colorless, tasteless, and nonirritating gas. The
most common causes of CO exposure are
fires, faulty combustion heating systems,
exhaust from internal combustion engines,
and heating gases other than natural gas (1).
When breathed in, CO competes with oxy-
gen in the blood, binding to hemoglobin in
place of the oxygen and interfering with the
oxygenation of tissues. The afﬁnity of CO to
hemoglobin is approximately 200 times
greater than that of oxygen, making it a very
effective mechanism to displace oxygen (2).
Although the neurotoxicant effect of CO
exposure was initially believed to be a result
of hypoxia secondary to the displacement of
oxygen, it is now believed that additional
mechanisms are involved, including the sup-
pression of mitochondrial oxydatic respira-
tion and cardiomyopathy, with the associated
hypotension and systemic acidosis (1).
The most common pathological ﬁndings
on MRI for patients with CO exposure
include bilateral necrosis in the globus pal-
lidus and bilateral hyperintensities in periven-
tricular white matter (3,4). The white matter
changes are thought to represent reversible
demyelination (3). Vieregge et al. (5) reported
that the white matter changes were more pre-
dictive of outcome than the globus pallidus
changes. Although the vast majority of lesions
reported in the literature are in the globus
pallidus and white matter, lesions in other
brain areas have been reported, including the
hippocampus (6), thalamus, medial temporal
lobe, cerebellum (1), parietal lobe, occipital
lobe, and frontal lobe (7).
The early symptoms of CO exposure are
not easily identiﬁed because they are nonspe-
ciﬁc (1). Symptoms include nausea, headache,
weakness, irritability, confusion, visual distur-
bances, parkinsonism, persistent vegetative
state, akinetic mutism, agnosia, apraxia, con-
fabulation, depression, delirium, and psy-
chosis (8). Patients may present with ﬂu-like
symptoms or symptoms consistent with a bac-
terial or viral infection, and may, therefore, be
misdiagnosed (8). As the level of exposure to
CO increases, the level of consciousness
decreases, further jeopardizing quick and
accurate identiﬁcation of the exposure (1) and
potentially leading to coma or death. The rela-
tion of CO levels, serum carboxyhemoglobin
levels, and symptoms were outlined by
O’Donoghue (9) (Table 2).
CO exposure is somewhat unusual in that
a person may have an initial change in con-
sciousness due to the exposure, recover from
the acute stage (or show no initial symptoms),
be asymptomatic for several days to several
weeks, and then have an exacerbation with
neurologic and/or psychiatric symptoms. Choi
(10) reported that of 2,360 patients examined
for CO intoxication, 2.75% had delayed neu-
rologic sequelae, and of the 549 of those
patients who were admitted to the hospital,
11.8% had delayed neurologic sequelae. Choi
(10) reported that the the patients were symp-
tom-free for 2–40 days, with a mean of 22.4
days and a mode of 1–4 weeks. (It is notewor-
thy, however, that the patients in Choi’s
report were not administered neuropsycholog-
ical tests, which are now generally regarded as
being more sensitive to sequelae than physi-
cal/neurologic examinations.) The delay of
onset of neurologic and neuropsychological
symptoms is believed to be due to a progres-
sive demyelination in the white matter (3).
The identiﬁcation of CO exposure by lab-
oratory tests is imprecise, making it difﬁcult
to determine the degree of exposure. The
most commonly used physical marker is
blood carboxyhemoglobin (HbCO) levels.
The half-life of HbCO is 4–5 hr in room air
free of CO (11) and 45–80 min when an
individual has been at rest breathing 100%
oxygen (11), making the utility of HbCO
testing largely ineffective. Although serum
HbCO levels, if elevated, do provide evidence
of exposure to CO and, if precise time mea-
surements are known, it can suggest the level
of CO exposure, it does not reveal how severe
the poisoning was, nor does it predict delayed
sequelae (12). First, HbCO measurements
reﬂect only the blood levels and do not indi-
cate the degree of tissue involvement (13).
Second, a longer-term exposure to one level
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Table 1. Continued.
Domain and neuropsychological test Time 1 Time 2
Visuospatial
WAIS-III
Picture completion (age-scaled score) 9* 14
Picture arrangement (age-scaled score) 10* 13
Block design (age-scaled score) 17 15
Matrix reasoning (age-scaled score) 14 17
Boston Visuospatial Quantitative Battery
Qualitative ﬁndings Large; poor spatial planning; 
sometimes works right to left*
Rey-Osterreith complex ﬁgure test, copy
Raw score (percentile) 35 (75th–99th)* 34 (75th)*
Memory
WMS-R
Attention index NA 118*
General memory quotient NA 128
Verbal-verbal paired associate learning, immediate recall
Learning trials 2-0-0-4* 0-1-3-5*
Verbal-verbal paired associate learning, delayed recall
Learning trials 2/10* 6/10
Delayed recognition span test, verbal
Span, total 14, 14 14, 14
Recall (15 sec, 2 min recall) 6, 6* 7, 8
Forced choice recognition 12/14 12/14
Word Triads (Peterson) 15-14-7-7* 15-11-8-9*
Rey-Osterreith Complex Figure
Immediate recall
Raw score (percentile) 27 (75th)* 26.5 (50th–75th)*
Delayed recall
Raw score (percentile) 25 (50–75%)* 25.5 (50–75%)*
California Verbal Learning Test
Learning 6-9-9-14-13 7-10-12-12-15
(Total = 39)* (Total = 46)*
Recognition (free recall, forced choice) 15,* 16 15,* 16
Clusters 3-3-1-5-4* 1-2-3-3-5*
Qualitative Performance below expectation,
perseverations; poor strategy*
Motivation
Test of memory malingering
Trail 1 47 50
Trail 2 50 NA
Trail 3 50 NA
Minnesota Multiphasic Personality Inventory
Description of results Unacknowledged depression (all scales < 60)
Abbreviations: NA, not available; WAIS-III, Wechsler Adult Intelligence Scale, Third Edition; WMS-R, Wechsler Memory
Scale, Revised. Time 1, 15 April 1998; Time 2, 28 April 1999. 
aPerceptual error. *Scores and impressions are below expectation.of HbCO may result in more severe effects
than a shorter-term exposure at the same level
(11). Third, in clinical practice, patients do
not always reach the hospital within 4–5 hr of
exposure and precise time measurements are
rarely known, making the assessment of
HbCO levels insigniﬁcant. Indeed, Myers et
al. (14) asserted that HbCO levels are “of lit-
tle value in diagnosing either acute or chronic
CO poisoning” (p. 564). 
A second physical marker sometimes used
to evaluate CO exposure is CO in exhaled air
(11). This measurement can then be used to
approximate HbCO levels in cases where a
blood sample cannot be obtained. 
A third physical marker involves brain
MRIs. MRI ﬁndings can help to conﬁrm that
brain damage consistent with CO exposure has
occurred, but the lesions are nonspeciﬁc and,
often, exposed individuals have lesions in brain
areas other than globus pallidus or the white
matter, complicating diagnosis. In addition, as
was seen in the current case study, the small
lesions resulting from CO exposure can be
overlooked or interpreted as normal in a gener-
alized radiologic evaluation. Neurologic exami-
nations, too, often do not reveal the subtle
changes in functioning that may be seen in CO
exposure (12,14). A reliable physical marker to
determine the extent of CO poisoning has yet
to be found (13). Neuropsychological evalua-
tion, however, has been advocated as a more
sensitive and thus potentially useful tool to help
with differential diagnosis of CO-induced
encephalopathy (12–14).
A speciﬁc, distinctive pattern of deﬁcits on
neuropsychological testing has not been identi-
ﬁed in patients with CO exposure (8,15,16).
Rather, a wide range of deficits has been
reported. However, the majority of case reports
have described deﬁcits in memory (8,14–20),
visuospatial functioning (8,14,16,17,21) and
executive system functions (8,16,17), as well as
depression (15). Additional neuropsychologi-
cal findings in case reports of individuals
exposed to CO include deﬁcits in abstraction
(8,14,19), tactual apprehension of complex
stimuli (8), ﬁne manual motor control (8,14),
attention (8,15), cognitive processing speed
(14,19,20), and psychiatric and behavioral
symptoms (14,17,22–24).
Few case reports have been published
regarding the neuropsychological effects of
low-level (< 20% HbCO level), short-term
exposure to CO, and those that have been
reported show no effects or nonreplicable
effects (8). McNulty et al. (13) reported that
HbCO rates of < 10% are associated with
exposure to CO that was too low to cause
clinical symptoms. However, experimental
studies have revealed transient deficits in
functioning that are correlated with the sever-
ity and duration of exposure (2), even at low
levels of exposure (5–10% HbCO; 100 ppm
over 1–8 hr). These deficits can be detected
in memory and subjective mood states (25);
performance on divided attention tasks (26);
driving skills (27); visual vigilance (28); per-
formance on manual tasks (29); reaction
times (30); and memory, visuomotor coordi-
nation, visuospatial functioning, and atten-
tion (31). Benignus et al. (32) asserted that
none of the dose-effect studies of HbCO
using behavioral responses have been repli-
cated. However, they also pointed out that
the studies of HbCO were mainly done with
healthy young males at rest and may not gen-
eralize to other populations (32).
Although chronic (as opposed to short-
term) low-level exposure may produce more
notable neuropsychological deﬁcits, it is rare
to ﬁnd reports in the literature of patients who
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Figure 1. MRI of a 45-year-old woman exposed to CO. The MRI was performed 15 months after CO expo-
sure was reported and revealed multiple small lesions bilaterally in the basal ganglia (arrows) consistent
with chronic CO exposure.
Table 2. Human responses and approximate ambient CO air levels at various carboxyhemoglobin concentrations.
CO concentration producing 
%HbCO HbCO saturation (ppm)a Human responses and situations associated with HbCO levels
0.3–0.7 1–3 Normal range due to endogenous CO production
1–5 5–30 Selective increase in blood ﬂow to compensate for reduced blood oxygen-carrying capacity; with advanced
cardiovascular disease, cardiac reserve may be insufﬁcient to compensate; major urban expressway CO levels 
may reach 25 ppm during peak trafﬁc levels
5–9 30–60 Visual light threshold increased; chest pain occurs with less exertion in patients with angina pectoris; one to 
three pack per day cigarette smokers have similar HbCO levels
10–20 65–150 Slight headache; visual evoked response abnormal; may be lethal for those with severely compromised 
cardiac function; CO levels may exceed 100 ppm during weather inversions
20–30 150–300 Throbbing headache; ﬁne manual dexterity abnormal; dizziness, hypernea, and palpitations with exertion
30–40 300–700 Severe headache; nausea; vomiting; confusion; increased heart and respiratory rates especially with exertion; 
syncope
40–50 500–700 Progressive worsening of all symptoms; vision, hearing, and intellect impaired; incoordination
50–60 700–1,000 Coma and convulsions
60–70 1,000–2,000 Coma, cardiorespiratory depression, lethal if untreated
94 10,000 Coma without headache, nausea, and vomiting
99 50,000 May induce fatal cardiac arrhythmia and death without signiﬁcantly elevating carboxyhemoglobin
%HbCO, carboxyhemoglobin blood saturation. Data from O’Donoghue (9).
aApproximate CO concentrations producing sated blood HbCO saturation (ppm).have CO exposure without loss of conscious-
ness (15), which is more likely the case in a
low-level exposure situation. Ryan (15)
reported a case of a woman with a 3-year his-
tory of low-level CO exposure who demon-
strated likely effects of the exposure including
depression, difﬁculty tracking verbal informa-
tion, and difficulty retrieving newly learned
verbal and visual information. It may be that
few clinical case reports of low-level exposure
to CO are in the literature because, without
loss of consciousness or independent identiﬁ-
cation of CO leaks, patients are misdiagnosed.
Recovery from CO exposure is variable,
depending on the degree and chronicity of
exposure (8). Although patients may recover
spontaneously, it is rare (15). Smith and
Brandon (33) reported that only 8 of 63
patients with acute CO poisoning improved
after an average of 3 years, and 17 indicated
that their memory had worsened. In contrast,
Choi (10) reported that 59% of the 549 hos-
pitalized patients with CO intoxication had
recovered “without any sequelae,” and 27 of
the 36 hospitalized patients (75%) who
showed delayed sequelae displayed recovery
after 1 year, although 5 had persistent mild
memory problems and 1 had parkinsonism.
However, as mentioned above, the patients in
Choi’s study (10) were not administered neu-
ropsychological tests, which may have
revealed persistent deﬁcits that were missed in
a neurologic evaluation.
Conclusion
Although CO poisoning manifests itself in a
variety of neuropathologic, neurologic, and
neuropsychological sequelae, the most consis-
tent ﬁndings include bilateral necrosis in the
basal ganglia, bilateral hyperintensities in the
periventricular white matter, headaches and
other ﬂu-like symptoms, memory disturbance,
deﬁcits in visuospatial functioning, and execu-
tive system signs. As discussed above, our
patient displayed many of these more com-
mon signs and symptoms, including bilateral
basal ganglia lesions, headache and flu-like
symptoms, memory difficulties (specifically
retrieval of newly learned information), and
executive system dysfunction. Deckel (17)
asserted that the frontal lobe deficits often
seen in patients with CO exposure may be
caused indirectly by disruption in the func-
tioning of the basal ganglia as well as the
white-matter tissue that connects the frontal
lobes with other brain areas. The patient was
seen in follow-up 1 year after the ﬁrst testing
to monitor any progression; at that time, no
signiﬁcant evidence of progression was seen.
This case provides further evidence that
routine neurologic examinations may miss
sequelae to CO exposure that can be picked up
by careful neuropsychological evaluation. Even
the routine clinical MRI reading missed the
evidence of CO exposure. By administering a
complete battery of neuropsychological tests to
this patient with chronic, low-level exposure
and no history of unconsciousness at exposure,
a pattern of deﬁcits was revealed that was simi-
lar to that often reported in the literature in
cases of more severe CO exposures.
Findings in this case are typical of those we
have seen in our clinic among patients with
chronic CO exposure, no loss of consciousness,
and positive MRI ﬁndings. The absence of doc-
umentation of chronic or acute levels of CO
exposure is also typical, with detection of a leak
leading to identiﬁcation of faulty ventilation
and CO exposure at home or in the workplace.
In most of these cases, reliable documentation
of acute levels of exposure on the day of detec-
tion are unavailable; in virtually none of these
cases are chronic exposure levels available. In
such situations, one must rely on clinical out-
comes to document health effects of such expo-
sures. This case is somewhat unusual in the
clarity of the neuropsychological and neu-
roimaging findings, which we see in only a
minority of patients referred for evaluation of
possible effects of chronic or acute CO expo-
sure without loss of consciousness.
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